Implant Sciences [IMSC]

4Q14               4Q13               FY14               FY15              

Sales                            $1.5M              $2.4M              $8.63M            $12M

Net Inc.                       ($5.7M, 0.09)  ($5.5M, 0.10)($21M, 0.35)     ($27.4M, 0.56)

Losses in the quarter widened on lower sales, higher operating expenses and increased interest expense, partially offset by a $1.3 million decrease in stock-based compensation expense. Sales fell 36% due to a 40% decline in sales of the QS-B220 desktop explosives trace detector (ETD) and a 21% decline in the number of QS-H150 handheld ETD units sold. The average unit price of the H-150 also fell by 8%. Sales of parts and suppliers were also lower.